Article info
PDFCase Reports: Novel treatment (new drug/interventions; established drug/procedure in new situation)
Improvement of SLC29A3 spectrum disorder-related sensorineural hearing loss after initiation of IL-6 inhibitor
- Correspondence to Dr Amer Khojah; khojah.a{at}gmail.com
Citation
Improvement of SLC29A3 spectrum disorder-related sensorineural hearing loss after initiation of IL-6 inhibitor
Publication history
- Accepted June 5, 2022
- First published June 22, 2022.
Online issue publication
July 04, 2023
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© BMJ Publishing Group Limited 2022. No commercial re-use. See rights and permissions. Published by BMJ.